Skip to main content

Advertisement

SpringerLink
Log in

Triple Negative Breast Cancer: Experience from a North Indian Tertiary Care Center

  • Original Article
  • Published:
Indian Journal of Surgery Aims and scope Submit manuscript

Abstract

Triple negative breast cancer (TNBC) is characterized by absence of estrogen and progesterone receptors (ER and PR) expression and lack of amplification of HER2 gene expression. It accounts for 15–20% of all breast cancer worldwide. The aim of the study was to determine the prevalence of TNBC patients visiting Surgery Department of Banaras Hindu University and correlate various clinico-pathological parameters vis-a-vis non-TNBC patients. TNBC accounted for 64/196 (32.6%) of all breast cancer patients. TNBC patients presented at a younger age (49 versus 55 years) compared to non-TNBC patients. TNBC patients had a higher chance of lymph node involvement (84 versus 75%), more grade III lesions (64 versus 50%), higher chance of lympho-vascular invasion (62.5 versus 45.5%) compared to non-TNBC patients. On follow-up of 36 months, the incidence of locoregional recurrence was 26.5% and distant metastasis 17.2% among TNBC patients compared to 16.6 and 12% respectively for non-TNBC patients. None of the TNBC patients developed bone metastasis which was seen in 7 of the non-TNBC patients. Stage for stage TNBC tumors had a worse histological profile and higher incidence of locoregional and distant metastases compared to non-TNBC patients. Although the prevalence of TNBC in our study was three times higher than reported worldwide yet their biological behavior is by and large similar to those reported worldwide.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Chacon RD, Costanzo MV (2010) Triple-negative breast cancer. Breast Cancer Res 12(Suppl 2):53

    Google Scholar 

  2. Brenton JD, Carey LA, Ahmed AA, Caldas C (2005) Molecular classification and molecular forecasting of breast cancer: ready for clinical application? J Clin Oncol 23:7350–7360

    Article  CAS  Google Scholar 

  3. Hurvitz S, Mead M (2016) Triple negative breast cancer: advancements in characterization and treatment approach. Curr Opin Obstet Gynecol 28:59–69

    PubMed  Google Scholar 

  4. Hammond MEH, Hayes DF, Dowsett M (2010) American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J Clin Oncol 28:2784–2795

    Article  Google Scholar 

  5. Stockmans G, Deraedt K, Wildiers H, Moerman P, Paridaens P (2008) Triple negative breast cancer. Curr Opin Oncol 20:614–620

    Article  Google Scholar 

  6. Reis-Filho JS, Tutt AN (2008) Triple negative tumours: a critical review. Histopathology 52:108–118

    Article  CAS  Google Scholar 

  7. Chopra B, Kaur V, Singh K, Verma M, Singh S, Singh A (2014) Age shift: breast cancer is occurring in younger age groups—is it true? Clinical Cancer Investigation Journal 3(6):526–529

    Article  Google Scholar 

  8. Perou CM, Sorlie T, Eisen MB et al (2000) Molecular portraits of human breast tumours. Nature 406:747–752

    Article  CAS  Google Scholar 

  9. Tan DS, Marchio C, Jones RL et al (2008) Triple negative breast cancer: molecular profiling and prognostic impact in adjuvant anthracycline treated patients. Breast Cancer Res Treat 111:27–44

    Article  CAS  Google Scholar 

  10. Dent R, Trudeau M, Pritchard K et al (2007) Triple negative breast cancer: clinical features and patterns of recurrence. Clin Cancer Res 13:4429–4434

    Article  Google Scholar 

  11. Suresh P, Batra U, Doval DC (2013) Epidemiological and clinical profile of triple negative breast cancer at a cancer hospital in North India. Indian J Med Paediatr Oncol 34:89–95

    Article  CAS  Google Scholar 

  12. Bauer KR, Brown M, Cress RD, Parise CA, Caggiano V (2007) Descriptive analysis of estrogen receptor (ER) negative, progeterone receptor (PR) negative and HER2 negative invasive breast cancer, the so called triple negative phenotype: a population based study from the California Cancer Registry. Cancer 109(9):1721–1728

    Article  Google Scholar 

  13. Rakha EA, Tan DS, Foulkes WD et al (2007) Are triple negative tumours and basal like breast cancer synonymous? Breast Cancer Res 9(6):404

    Article  Google Scholar 

  14. Li CY, Zhang S, Zhang XB et al (2013) Clinicopathological and prognostic characteristics of triple negative breast cancer (TNBC) in Chinese patients: a retrospective study. Asian Pac J Cancer Prev 14(6):3779–3784

    Article  Google Scholar 

  15. Zubeda S, Kaipa PR, Shaik NA et al (2013) HER-2/neu status: a neglected marker of breast cancer patients in India. Asian Pac J Cancer Prev 14(4):2231–2235

    Article  Google Scholar 

  16. Sharma M, Sharma JD, Sarma A et al (2015) Triple negative breast cancer in people of North East India: critical insights gained at a Regional Cancer Centre. Asian Pac J Cancer Prev 15(11):4507–4511

    Article  Google Scholar 

  17. Akhtar M, Dasgupta S, Rangwala M (2015) Triple negative breast cancer: an Indian perspective. Breast Cancer: Targets and Therapy 7:239–243

    Google Scholar 

  18. Lakshmaiah KC, Das U, Suresh TM, Lokanatha D, Babu GK, Jacob LA, Babu S (2014) A study of triple negative breast cancer at a tertiary cancer centre in Southern India. Ann Med Health Sci Res 4:933–937

    Article  CAS  Google Scholar 

  19. Fulford LG, Reis-Filho JS, Ryder K et al (2007) Basal like grade III invasive ductal carcinoma of the breast: patterns of metastasis and long term survival. Breast Cancer Res 9:R4

    Article  Google Scholar 

  20. Gaedcke J, Traub F, Milde S et al (2007) Predominance of the basal type and HER-2/neu type in brain metastasis from breast cancer. Mod Pathol 20:864–867

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Institute of Medical Sciences, Banaras Hindu University, Varanasi, 221005, India

    Rahul Khanna, Ram Niwas Meena, Akash Bansal, Shashi Prakash Mishra & Seema Khanna

  2. Department of Pathology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, 221005, India

    S. C. U. Patne

  3. Division of Biostatistics, Institute of Medical Sciences, Banaras Hindu University, Varanasi, 221005, India

    Tej Bali Singh

Authors
  1. Rahul Khanna
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ram Niwas Meena
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Akash Bansal
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. S. C. U. Patne
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Shashi Prakash Mishra
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Tej Bali Singh
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Seema Khanna
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Rahul Khanna.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Khanna, R., Meena, R.N., Bansal, A. et al. Triple Negative Breast Cancer: Experience from a North Indian Tertiary Care Center. Indian J Surg 80, 474–478 (2018). https://doi.org/10.1007/s12262-017-1638-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12262-017-1638-7

Keywords

Search

Navigation